NEU 3.32% $20.52 neuren pharmaceuticals limited

Share Price, page-2774

  1. 1,937 Posts.
    lightbulb Created with Sketch. 34
    The Motley Fool's incorrect reporting may promote some buying this afternoon... lol:

    Neuren Pharmaceuticals Ltd (ASX: NEU)

    Neuren Pharmaceuticals is our first All Ords share to check out. Neuren is having a pretty fabulous day. The company is presently up a decent 1.64% at $8.67 a share.

    But this morning, Neuren shares spiked as high as $8.80 each. That is not only a new 52-week high for the Neuren Pharmaceuticals share price, but the highest Neuren has traded since way back in early 2007.

    Yes, Neuren is trading at a post-GFC high today. Neuren shares are now up more than 120% year to date. It’s not hard to see why.

    In a quarterly update last month, Neuren announced a new drug has been approved by the US Food and Drug Administration (FDA). The company is anticipating revenue from this new drug alone of $112 million in 2023.

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.